Solar Biotech Acquires Noblegen
July 25, 2023
Solar Biotech Inc., a Norton, Virginia-based synthetic biology and bioprocessing company, has acquired Noblegen, an advanced digital biology and precision fermentation company based in Peterborough, Ontario. Noblegen will operate as Solar Biotech Canada and serve as the group's food-grade-certified biomanufacturing and R&D hub, expanding Solar Biotech's upstream/downstream capabilities and on‑the‑ground capacity in Canada.
- Buyers
- Solar Biotech Inc.
- Targets
- Noblegen
- Industry
- Biotechnology
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Pictor Biotech (d.b.a. SOLARBIOTECH) Unifies with GPC Bio and Eleszto Genetika Under Single Ownership
January 23, 2025
Biotechnology
Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio and Eleszto Genetika announced their acquisition and strategic unification under a single owner, creating a vertically integrated synthetic biology and biomanufacturing organization. The consolidation brings together decades of expertise across strain engineering, bioprocess development, plant engineering and automation to accelerate precision fermentation from R&D to commercial production.
-
Ginkgo Bioworks Acquires Novogy's Microbial Engineering Platform
December 16, 2020
Biotechnology
Ginkgo Bioworks acquired the main assets of Novogy, Inc., absorbing Novogy's strain assets, IP portfolio, codebase and most of its technical team. The acquisition brings Novogy's expertise in lipid-producing oleaginous yeasts (notably Yarrowia lipolytica) into Ginkgo's cell‑programming platform to accelerate development of bio-based oils, chemicals and materials.
-
OmniActive Health Technologies Acquires ENovate Biolife
November 4, 2024
Food & Beverage
OmniActive Health Technologies has acquired ENovate Biolife to expand its portfolio of clinically validated botanical and specialty active ingredients for dietary supplements, functional foods and sports nutrition. The acquisition strengthens OmniActive's R&D, clinical and commercial capabilities and aims to accelerate global distribution of ENovate's ingredients such as Muvz, RedNite and Oxyjun.
-
Quintara Biosciences Acquires Laragen Sanger Sequencing Business from Transnetyx
September 15, 2025
Biotechnology
Quintara Biosciences has completed the acquisition of the Laragen Sanger Sequencing business (formerly operated by Transnetyx), effective September 15, 2025. The purchase preserves local operations and customer service in Los Angeles while expanding Quintara’s California sequencing footprint and capabilities.
-
Solo Acquires SolarNexus
September 12, 2023
Renewable Energy
Solo, a Lehi, Utah-based provider of solar sales and design software, has acquired SolarNexus, a San Francisco-based solar customer-relationship and business management software provider. The acquisition will integrate SolarNexus' CRM and operations capabilities into Solo's platform to expand product capabilities and accelerate innovation for solar installers, EPC partners and sales teams.
-
Sunshine Biopharma Inc. Acquires Nora Pharma Inc.
October 20, 2022
Pharmaceuticals
Sunshine Biopharma Inc. has completed the acquisition of all outstanding shares of Nora Pharma Inc., making Nora Pharma a wholly owned subsidiary. The deal (C$30.0 million) expands Sunshine’s business into generic prescription drugs, over‑the‑counter products and biosimilars and adds approximately $10.7 million in revenue and 36 employees based in the Greater Montreal area.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.